Safety and Pharmacodynamic Study of CD-NP
NCT00482937 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 22
Last updated 2007-06-06
Summary
The primary objective of this study is to establish the safety of CD-NP in normal human volunteers.
Conditions
- Heart Failure, Congestive
Interventions
- DRUG
-
CD-NP
Sponsors & Collaborators
-
Nile Therapeutics
lead INDUSTRY
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2007-01-31
- Completion
- 2007-05-31
Countries
- United States
Study Locations
More Related Trials
-
Evaluating the Safety and Plasma Levels of N-Methanocarbathymidine (N-MCT) in Normal Patients
NCT02778386 ·Status: UNKNOWN ·Phase: PHASE1
-
A Study to Evaluate the Pharmacokinetics and Safety of Diluted vs. Undiluted Intravenous DA-5217 in Healthy Adult Subjects
NCT07027982 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Determine the Potential DDIs When the Daclatasvir/Asunaprevir/BMS-791325 Three Drug Antiviral Combination Tablet (FDC) is Coadministered With a Cocktail of Cytochrome P450 (CYP) Probe Substrates and Transporter Probe Substrates (Digoxin and Pravastatin) in Healthy Subjects
NCT02045966 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Study to Evauate the Pharmacokinetic Profiles and Safety of CKD-348 in Healthy Volunteers
NCT04304547 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Hepatic Impairment on the Pharmacokinetics of a Single Dose of TD-9855
NCT04200573 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics and Safety/Tolerability After Oral Administration of CKD-387 and D635 Under Fed Condition
NCT03849339 ·Status: UNKNOWN ·Phase: PHASE1
-
Study of NST-6179 in Healthy Subjects
NCT05181085 ·Status: COMPLETED ·Phase: PHASE1
-
A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386(2)
NCT04694989 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Compare the Safety, Tolerability, and Pharmacokinetics of CTP-692 Versus D-serine in Healthy Volunteers
NCT03778320 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics and Safety/Tolerability After Oral Administration of CKD-387 and D635 in Healthy Adults
NCT03849261 ·Status: UNKNOWN ·Phase: PHASE1
-
A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(3)
NCT05192356 ·Status: COMPLETED ·Phase: PHASE1
-
Open-label Study to Evaluate the Effects of NST-1024 on the PK of Multiple Drugs in Healthy Subjects
NCT05368831 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetic Study of Stiripentol and Its Metabolites After Multiple Dose Oral Administration in Healthy Male Volunteers
NCT03866928 ·Status: COMPLETED ·Phase: PHASE1
-
Midodrine in Hepatopulmonary Syndrome
NCT03600870 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Test the Safety and Tolerability of Single and Multiple Doses of Padsevonil in Adult and Elderly Study Participants
NCT04013191 ·Status: COMPLETED ·Phase: PHASE1
-
A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386(2) 80/20/10mg
NCT04987970 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics and Safety/Tolerability After Oral Administration of CKD-387 and D484 in Healthy Adults
NCT03646799 ·Status: UNKNOWN ·Phase: PHASE1
-
A Study to Evaluate the Safety, Tolerability Pharmacokinetics, and Pharmacodynamics of a New Spray Dried Dispersion (SDD) Formulation of CC-11050 After Single Dose of CC-11050 and to Evaluate the Pharmacokinetics of CC-11050 Under Fasted and Fed Conditions and After Coadministration With Omeprazole
NCT04139226 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of OP-101 After Intravenous Administration in Healthy Volunteers
NCT03500627 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase 1 Clinical Trial of NTQ5082 in Healthy Volunteers
NCT06560593 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Study of the Tolerability, Pharmacokinetics, and Pharmacodynamics of INS50589 Intravenous Infusion in Healthy Volunteers
NCT00099450 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed)
NCT04083846 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Pharmacokinetics and Safety of DBPR108 in Subjects With Hepatic Impairment
NCT04859426 ·Status: COMPLETED ·Phase: PHASE1
-
"Pharmacokinetic Study of Nicotinamide Riboside"
NCT02689882 ·Status: COMPLETED ·Phase: PHASE1
-
Absorption, Metabolism, and Excretion Study of [14C]-TNP-2092
NCT05074134 ·Status: COMPLETED ·Phase: PHASE1